What Sierra Oncology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Dilly Stephen George | CEO and President | Jul 01 | Disposition to Issuer · D | −5,000 | $55.00 | −$275K | 0 |
| Klencke Barbara | Chief Medical Officer | Jul 01 | Disposition to Issuer · D | −5,000 | $55.00 | −$275K | 0 |
| Klencke Barbara | Chief Medical Officer | Jul 01 | Disposition to Issuer · D | −10,000 | $55.00 | −$550K | 0 |
| Collard Craig A | Director | Jul 01 | Disposition to Issuer · D | −13,500 | $55.00 | −$743K | 0 |
| Allen Andrew R | Director | Jul 01 | Disposition to Issuer · D | −1,650 | $55.00 | −$90.8K | 0 |
| Ashiya Mona | Director | Jul 01 | Disposition to Issuer · D | −226,704 | $55.00 | −$12.5M | 0 |
| Ashiya Mona | Director | Jul 01 | Disposition to Issuer · D | −226,704 | $55.00 | −$12.5M | 0 |
| Ashiya Mona | Director | Jul 01 | Disposition to Issuer · D | −1,511,362 | $55.00 | −$83.1M | 0 |
| Vivo Opportunity, Llc | Director | Jul 01 | Disposition to Issuer · D | −431,947 | $55.00 | −$23.8M | 0 |
| Vivo Opportunity, Llc | Director | Jul 01 | Disposition to Issuer · D | −2,735,853 | $55.00 | −$150M | 0 |
| Vivo Opportunity, Llc | Director | Jul 01 | Disposition to Issuer · D | −161,712 | $55.00 | −$8.89M | 0 |
| Sinclair Andrew | Director | Jul 01 | Disposition to Issuer · D | −1,314,127 | $55.00 | −$72.3M | 0 |
| Orbimed Advisors Llc | Director | Jul 01 | Disposition to Issuer · D | −226,704 | $55.00 | −$12.5M | 0 |
| Orbimed Advisors Llc | Director | Jul 01 | Disposition to Issuer · D | −226,704 | $55.00 | −$12.5M | 0 |
| Orbimed Advisors Llc | Director | Jul 01 | Disposition to Issuer · D | −1,511,362 | $55.00 | −$83.1M | 0 |
| Aggarwal Gaurav | Director | Jul 01 | Disposition to Issuer · D | −2,735,853 | $55.00 | −$150M | 0 |
| Longitude Capital Partners III, Llc | 10% owner | Apr 27 | Other Transaction · J | +840 | — | — | 8,015 |
| Longitude Capital Partners III, Llc | 10% owner | Apr 27 | Other Transaction · J | +252 | — | — | 2,404 |
| Longitude Capital Partners III, Llc | 10% owner | Apr 27 | Other Transaction · J | +588 | — | — | 5,611 |
| Longitude Capital Partners III, Llc | 10% owner | Apr 27 | Other Transaction · J | +7,175 | — | — | 7,175 |
Loading...